Received Nov 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z012111 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z008428 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z008873 | — |
inadvertently administering VARIVAX and PROQUAD after temperature excursion; No additional AE; This spontaneous report has been received from other health professional, regarding to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with improperly stored dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Z008873, expiration date: 14-May-2027, Z008428 expiration date: 06-May-2027) and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot #Z012111, expiration date: 19-Jan-2027) in combination with sterile diluent, all administered as prophylaxis. The administered doses were stored at a temperature of 6.9 degrees Fahrenheit (F) during a time frame of 10 minutes (product storage error). There was no previous temperature excursion. No additional side effects were reported in the patients. This case was determined to be non-valid due to the lack of patient identifiers.
Sterile diluent